SYNLOGIC, INC. (Nasdaq:SYBX)
Health Care/Life Sciences • Biotechnology
CIK 1527599
Company
Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.
Address
301 Binney Street
Suite 402
Cambridge, Massachusetts 02142
301 Binney Street
Suite 402
Cambridge, Massachusetts 02142
Employees
6
6
Stock Info
Close
$1.3100
$1.3100
Day Range
1.2600 - 1.3700
1.2600 - 1.3700
52 Week Range
1.2200 - 2.0400
1.2200 - 2.0400
Average volume
36.94K
36.94K
Short Interest
55.19K (02/14/25)
55.19K (02/14/25)
% of Float Shorted
0.76%
0.76%
Market Cap
$14.97M
$14.97M
Revenue
$3.37M
$3.37M
Net Income
-$57.28M
-$57.28M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Director James Flynn |
Independent Chairman Peter Barrett |
Independent Director Edward T. Mathers |
Independent Director Richard P. Shea |
SEC filings
Date | Form | Event |
---|---|---|
5 Dec, 2024 | 8-K | |
14 Nov, 2024 | SC 13G/A | |
12 Nov, 2024 | 8-K | |
12 Nov, 2024 | 10-Q | |
12 Nov, 2024 | S-8 | |
12 Nov, 2024 | S-8 | |
6 Nov, 2024 | DEF 14A | |
5 Nov, 2024 | ARS | |
30 Oct, 2024 | 4 | |
8 Aug, 2024 | 10-Q | |
8 Aug, 2024 | 8-K | |
16 May, 2024 | SC 13D/A | |
14 May, 2024 | 8-K | |
14 May, 2024 | 10-Q | |
29 Apr, 2024 | 10-K/A | |
22 Apr, 2024 | 144 | |
18 Apr, 2024 | SC 13G | |
4 Apr, 2024 | 4 | |
4 Apr, 2024 | 4 | |
21 Mar, 2024 | 144 | |
21 Mar, 2024 | 4 | |
21 Mar, 2024 | 8-K | |
21 Mar, 2024 | 3 | |
21 Mar, 2024 | 3 | |
19 Mar, 2024 | 8-K | |
19 Mar, 2024 | 10-K | |
22 Feb, 2024 | 8-K | CEO Change |
20 Feb, 2024 | 8-A12B | |
20 Feb, 2024 | 8-K | |
16 Feb, 2024 | 3 | |
16 Feb, 2024 | SC 13D | |
14 Feb, 2024 | SC 13G | |
14 Feb, 2024 | SC 13G/A | |
12 Feb, 2024 | 8-K | CEO Change |
9 Feb, 2024 | SC 13G/A | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
29 Dec, 2023 | 8-K | |
17 Nov, 2023 | 8-K | |
15 Nov, 2023 | 8-K | |
14 Nov, 2023 | 4 | |
14 Nov, 2023 | 4 | |
14 Nov, 2023 | 4 | |
9 Nov, 2023 | 10-Q | |
9 Nov, 2023 | 8-K | |
7 Nov, 2023 | 8-K | |
13 Oct, 2023 | SC 13D/A | |
13 Oct, 2023 | SC 13G/A | |
10 Oct, 2023 | SC 13G/A | |
6 Oct, 2023 | 3 | |
4 Oct, 2023 | SC 13D/A | |
2 Oct, 2023 | 424B4 | |
29 Sep, 2023 | 8-K | |
28 Sep, 2023 | S-1MEF | |
28 Sep, 2023 | S-1/A | |
28 Sep, 2023 | EFFECT | |
28 Sep, 2023 | 8-K | |
27 Sep, 2023 | S-1/A | |
26 Sep, 2023 | CORRESP | |
26 Sep, 2023 | CORRESP | |
25 Sep, 2023 | UPLOAD | |
22 Sep, 2023 | 8-K | |
20 Sep, 2023 | CORRESP | |
15 Sep, 2023 | UPLOAD | |
11 Sep, 2023 | UPLOAD | |
8 Sep, 2023 | S-1 | |
1 Sep, 2023 | DEF 14A | |
21 Aug, 2023 | PRE 14A | |
16 Aug, 2023 | 8-K | |
10 Aug, 2023 | 8-K | |
10 Aug, 2023 | 10-Q | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
15 Jun, 2023 | 8-K | |
5 Jun, 2023 | 8-K | |
11 May, 2023 | 8-K | |
11 May, 2023 | 10-Q | |
1 May, 2023 | DEFA14A | |
1 May, 2023 | ARS | |
1 May, 2023 | DEF 14A | |
21 Apr, 2023 | PRE 14A | |
5 Apr, 2023 | 4 | |
5 Apr, 2023 | 4 | |
5 Apr, 2023 | 4 | |
4 Apr, 2023 | 424B5 | |
29 Mar, 2023 | 10-K | |
29 Mar, 2023 | S-8 | |
29 Mar, 2023 | S-8 | |
29 Mar, 2023 | 8-K | |
14 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G/A | |
20 Jan, 2023 | SC 13G | |
20 Jan, 2023 | SC 13G/A | |
19 Jan, 2023 | 8-K | |
4 Jan, 2023 | 4 | |
4 Jan, 2023 | 4 | |
15 Dec, 2022 | 8-K | |
9 Dec, 2022 | 8-K | |
30 Nov, 2022 | 8-K | |
23 Nov, 2022 | 8-K | |
10 Nov, 2022 | 8-K | |
10 Nov, 2022 | 10-Q | |
18 Oct, 2022 | 8-K | |
6 Sep, 2022 | 8-K | |
11 Aug, 2022 | 8-K | |
11 Aug, 2022 | 10-Q | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 8-K | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
25 May, 2022 | 4 | |
12 May, 2022 | 8-K | |
12 May, 2022 | 10-Q | |
27 Apr, 2022 | DEF 14A | |
27 Apr, 2022 | DEFA14A | |
6 Apr, 2022 | 4 | |
6 Apr, 2022 | 4 | |
17 Mar, 2022 | S-8 | |
17 Mar, 2022 | S-8 | |
17 Mar, 2022 | 8-K | |
17 Mar, 2022 | 10-K | |
3 Mar, 2022 | 8-K | |
3 Mar, 2022 | 3 | |
3 Mar, 2022 | 4 | |
9 Feb, 2022 | SC 13G/A | |
8 Feb, 2022 | 4 | |
8 Feb, 2022 | 4 | |
1 Feb, 2022 | 4 | |
24 Jan, 2022 | 8-K | |
5 Jan, 2022 | 4 | |
10 Nov, 2021 | 10-Q | |
10 Nov, 2021 | 8-K | |
9 Nov, 2021 | 8-K | |
1 Oct, 2021 | SC 13G | |
29 Sep, 2021 | SC 13D/A | |
23 Sep, 2021 | 424B5 | |
23 Sep, 2021 | 8-K | |
22 Sep, 2021 | 424B5 | |
20 Sep, 2021 | 8-K | |
12 Aug, 2021 | 10-Q | |
12 Aug, 2021 | 8-K | |
30 Jul, 2021 | EFFECT | |
30 Jul, 2021 | 8-K | |
29 Jul, 2021 | CORRESP | |
28 Jul, 2021 | UPLOAD | |
23 Jul, 2021 | S-3 | |
15 Jul, 2021 | 8-K | |
17 Jun, 2021 | 8-K | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
11 Jun, 2021 | 8-K | |
13 May, 2021 | 10-Q | |
13 May, 2021 | 8-K | |
10 May, 2021 | SC 13G | |
5 May, 2021 | 8-K | |
27 Apr, 2021 | DEFA14A | |
27 Apr, 2021 | DEF 14A | |
22 Apr, 2021 | 4 | |
22 Apr, 2021 | 4 | |
22 Apr, 2021 | SC 13D/A | |
19 Apr, 2021 | 424B5 | |
16 Apr, 2021 | 8-K | |
15 Apr, 2021 | 424B5 | |
14 Apr, 2021 | 8-K | |
29 Mar, 2021 | SC 13D/A | |
25 Mar, 2021 | S-8 | |
25 Mar, 2021 | 10-K | |
25 Mar, 2021 | S-8 | |
25 Mar, 2021 | 8-K | |
24 Mar, 2021 | 8-K | |
12 Mar, 2021 | 4 | |
12 Mar, 2021 | 4 | |
12 Mar, 2021 | 4 | |
8 Mar, 2021 | 8-K | |
11 Feb, 2021 | 3 | |
11 Feb, 2021 | 4 | |
10 Feb, 2021 | 8-K | |
10 Feb, 2021 | 424B5 | |
5 Jan, 2021 | 4 |
Last update:2025-03-06 12:06:35.281817
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.